Sign up here and take full advantage of MicrobiomePost‘s features.
Sign up

Isabelle de Cremoux (Seventure): ‘2023 Will Be an Excellent Year for Microbiome Research’ 

MicrobiomePost talked with Isabelle de Cremoux, CEO of Seventure Partners, about the news that will emerge in 2023.

During the 8th Microbiome Movement – Drug Development Summit, held in London at the end of January, MicrobiomePost discussed with Isabelle de Cremoux, CEO of Seventure Partners, a leading venture capital firm in Europe, about the first fecal microbiota product approved by FDA and the news that will emerge in 2023.

Most recent

HCPs Area

Industry

MicrobiomePost.com provides qualified scientific updates to healthcare professionals and to anyone who wants to know more about the microbiome

Published by Clorofilla Srl

Facebook-f Linkedin Twitter Youtube
© 2016-2024 Clorofilla Scientific Publishing

Via Podgora 12/A, 20122, Milan, Italy – VAT: IT05299040963

© ALL RIGHTS RESERVED

Read MicrobiomePost’s Privacy Policy